Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.68 -0.07 (-9.16%)
At close: Oct 20, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2021)

Updated

Scinai Immunotherapeutics' Current Leases was $249,000 in Q4 2021, up 22.7% from $203,000 a year earlier.

Analysis

Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2021) Analysis & Trends

  • In earlier years, Current Leases was $203,000 in FY2020 (+1.0%) and $201,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Scinai Immunotherapeutics 157,066.38 -8.11 Mn -1.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 249,000.00
Dec 31, 2020 203,000.00
Dec 31, 2019 201,000.00
API Access

Scinai Immunotherapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=SCNI&period=max&api_key=YOUR_API_KEY